Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1378/chest.107.6.1752 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Localised swelling at sites of dermal filler injections following administration of Covid-19 vaccines: a systematic review.
Singapore Med J
December 2024
Department of Otolaryngology, Lewisham and Greenwich NHS Trust, London, United Kingdom.
Introduction: Localised swelling at sites of filler injections has been reported in the Moderna mRNA-1273 coronavirus disease 2019 (COVID-19) vaccine trial.
Methods: We conducted a review of the existing data and literature on the potential pathophysiology for this adverse event and its potential management.
Results: Data from the Moderna and Pfizer COVID-19 vaccine Phase 3 trial and one case series were available.
A randomized control trial employing infraorbital nerve stimulation as a neural distractor during nasopharyngeal swab.
Ear Nose Throat J
September 2024
Department of Otolaryngology, Thomas Jefferson University, Philadelphia, PA, USA.
Introduction: With the global COVID-19 pandemic, nasopharyngeal swabbing has become commonplace and can occasionally cause discomfort, tearing, and anxiety.
Objective: To evaluate whether using a neural distraction device during nasopharyngeal swabbing can mitigate patient discomfort.
Methods: Participants were randomized into nasal swab with vibration first (treatment-control or Tc) or nasal swab without vibration first (control-treatment or Ct).
Localized surgical debridement for the management of orbital mucormycosis.
Indian J Ophthalmol
February 2022
Department of Ophthalmology, Deenanath Mangeshkar Hospital, Pune, Maharashtra, India.
Purpose: To describe the role of localized debridement and instillation of amphotericin B for the management of orbital mucormycosis post COVID-19 infection with a view to avoid exenteration.
Methods: The records of all patients with orbital mucormycosis post COVID-19 infection in the last 6 months from December 2020 to June 2021 were evaluated, and ten patients were identified who were successfully managed with localized debridement, that is, removing the fungal tissue and necrotic material and amphotericin B gel instillation locally. MRI scan was used to identify the area of fungal infiltration and presence of necrotic material.
Orbital magnetic resonance imaging profile and clinicoradiological correlation in COVID-19-associated rhino-orbital-cerebral mucormycosis: A single-center study of 270 patients from North India.
Indian J Ophthalmol
February 2022
Department of Medicine, SMS Medical College and Hospital, Jaipur, Rajasthan, India.
Purpose: To study the clinical profile and magnetic resonance imaging (MRI) features in patients of COVID-19-associated rhino-orbital-cerebral mucormycosis (CA-ROCM) with orbital involvement and perform a clinicoradiological correlation.
Methods: A cross-sectional study was performed at a tertiary care center in north India from May 2021 to June 2021. Consecutive patients with clinical, nasal endoscopic, and/or microbiological evidence of CA-ROCM underwent MRI of paranasal sinuses, orbit, and brain as per the study protocol.
Preseptal cellulitis and infraorbital abscess as a complication of a routine COVID-19 swab.
BMJ Case Rep
May 2021
Ophthalmology, Sherwood Forest Hospitals NHS Foundation Trust, Sutton-In-Ashfield, UK.
This case report describes a significant complication of a routine COVID-19 swab in a previously fit and well young patient who developed preseptal cellulitis and an infraorbital abscess as a consequence of the mentioned nasal swabbing. Other authors have previously reported various complications in connection with the use of nasal swabs, including retained swab fragments, epistaxis and cerebrospinal fluid leakage. To our knowledge, to date, this is the first reported case of an abscess as a consequence of COVID-19 swabbing.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!